1 |
World Health Organization. Global tuberculosis report: exclusive summary [Internet]. Geneva: World Health Organization; 2018 [cited 2019 Mar 21]. Available from: https://www.who.int/tb/publications/ global_report/tb18_ExecSum_web_4Oct18.pdf.
|
2 |
Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012;367:348-61.
DOI
|
3 |
World Health Organization. Roadmap for childhood tuberculosis: towards zero deaths [Internet]. Geneva: World Health Organization; 2013 [cited 2019 Mar 21]. Available from: https://apps.who.int/iris/bitstream/handle/10665/89506/9789241506137_eng.pdf.
|
4 |
Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health 2018;40:e2018036.
DOI
|
5 |
Stop TB Partnership; World Health Organization. An international roadmap for tuberculosis research: towards a world free of tuberculosis [Internet]. Geneva: World Health Organization; 2011 [cited 2019 Mar 21]. Available from: http://www.stoptb.org/assets/documents/resources/publications/technical/tbresearchroadmap.pdf.
|
6 |
Kang PS, Lee SK. A study on the effects of BCG vaccination against tuberculosis. Korean J Prev Med 1982;15:33-46.
|
7 |
Lee H, Cho SN, Kim HJ, Anh YM, Choi JE, Kim CH, et al. Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea. Vaccine 2011;29:6564-71.
DOI
|
8 |
Lee H, Dockrell HM, Kim DR, Floyd S, Oh SY, Lee JB, et al. The current status of BCG vaccination in young children in South Korea. Tuberc Respir Dis (Seoul) 2012;72:374-80.
DOI
|
9 |
Schrager LK, Harris RC, Vekemans J. Research and development of new tuberculosis vaccines: a review. F1000Res 2018;7:1732.
DOI
|
10 |
Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B, et al. Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa. Clin Vaccine Immunol 2017;24:e00439-16.
|
11 |
Scott KM, Lee HK, Ham SS, Park SO, Kim HD, Koh WH, et al. A study of household contacts of cases with pulmonary tuberculosis. Yonsei Med J 1962;3:74-8.
DOI
|
12 |
Medical Research Council Working Party. A controlled trial of plaster-of-paris jackets in the management of ambulant outpatient treatment of tuberculosis of the spine in children on standard chemotherapy. A study in Pusan, Korea. Second report of the Medical Research Council Working Party on Tuberculosis of the Spine. Tubercle 1973;54:261-82.
DOI
|
13 |
Oh HJ, Yoon HS, Bynn HS, Huh KY, Sohn C. Effects of rifampin (RMP) on liver function in tuberculous children. J Korean Pediatr Soc 1981;24:430-6.
|
14 |
Lee KS, Park KC, Shin MJ, Kang SC. Rifampin effects on tuberculous meningitis in children. J Korean Pediatr Soc 1978;21:543-51.
|
15 |
Stop TB Department; Department of Child and Adolescent Health and Development of the World Health Organization. A research agenda for childhood tuberculosis [Internet]. Geneva: World Health Organization; 2007 [cited 2019 Mar 22]. Available from: https://apps.who.int/iris/bitstream/handle/10665/69611/WHO_HTM_TB_2007.381_eng.pdf.
|
16 |
McIlleron H, Hundt H, Smythe W, Bekker A, Winckler J, van der Laan L, et al. Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes. Int J Tuberc Lung Dis 2016;20:915-9.
DOI
|
17 |
Child & Adolescent TB Working Group. Research priorities for paediatric tuberculosis [Internet]. New York, NY: Treatment Action Group; 2018 [cited 2019 Mar 22]. Available from: https://www.finddx.org/wp-content/uploads/2018/09/Paediatric_TB_ResearchPriorities_FINAL_Web.pdf.
|
18 |
Bekker A, Schaaf HS, Draper HR, van der Laan L, Murray S, Wiesner L, et al. Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHOrecommended treatment guidelines. Antimicrob Agents Chemother 2016;60:2171-9.
DOI
|
19 |
Denti P, Garcia-Prats AJ, Draper HR, Wiesner L, Winckler J, Thee S, et al. Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis. Antimicrob Agents Chemother 2018;62:e01521-17.
|
20 |
Garcia-Prats AJ, Draper HR, Finlayson H, Winckler J, Burger A, Fourie B, et al. Clinical and cardiac safety of long-term levofloxacin in children treated for multidrug-resistant tuberculosis. Clin Infect Dis 2018;67:1777-80.
DOI
|
21 |
McKenna L. The tuberculosis treatment pipeline for children [Internet]. New York, NY: Treatment Action Group; 2018 [cited 2019 Mar 22]. Available from: http://www.pipelinereport.org/2018/tb-peds-treatment-pipeline.
|
22 |
Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010;50 Suppl 3:S184-94.
DOI
|
23 |
Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 2012;55:1088-95.
DOI
|
24 |
Portevin D, Moukambi F, Clowes P, Bauer A, Chachage M, Ntinginya NE, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis 2014;14:931-8.
DOI
|
25 |
Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, et al. Performance of Xpert MTB/RIF and alternative specimen collection methods for the diagnosis of tuberculosis in HIV-infected children. Clin Infect Dis 2016;62:1161-8.
DOI
|
26 |
Walters E, van der Zalm MM, Palmer M, Bosch C, Demers AM, Draper H, et al. Xpert MTB/RIF on stool is useful for the rapid diagnosis of tuberculosis in young children with severe pulmonary disease. Pediatr Infect Dis J 2017;36:837-43.
DOI
|
27 |
LaCourse SM, Cranmer LM, Njuguna IN, Gatimu J, Stern J, Maleche-Obimbo E, et al. Urine tuberculosis lipoarabinomannan predicts mortality in hospitalized human immunodeficiency virus-infected children. Clin Infect Dis 2018;66:1798-801.
DOI
|
28 |
Sweeney TE, Braviak L, Tato CM, Khatri P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med 2016;4:213-24.
DOI
|
29 |
Huh S. Recent advances of medical journals in Korea and and further development strategies: is it possible for them to publish Nobel Prize-winning research? J Korean Med Assoc 2018;61:524-31.
DOI
|
30 |
Nafade V, Nash M, Huddart S, Pande T, Gebreselassie N, Lienhardt C, et al. A bibliometric analysis of tuberculosis research, 2007-2016. PLoS One 2018;13:e0199706.
DOI
|